CM 07337/CM/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1981	1
1982	6
1983	10
1984	6
1985	13
1986	5
1987	9
1988	5
1989	1
1990	2
1991	3
1992	1
1993	3
1994	2
1995	3
1996	1
1998	1
2024	0

1

Controversies in treatment of small cell carcinoma of the lung.

Shank B, Scher HI. Shank B, et al. Cancer Invest. 1985;3(4):367-87. doi: 10.3109/07357908509039798. Cancer Invest. 1985. PMID: 2992725 Review. No abstract available.

2

Phase II trials of methylglyoxal-bis (guanylhydrazone).

Kelsen DP, Yagoda A, Warrell R, Chapman R, Whittes R, Gralla RJ, Casper E, Young CW. Kelsen DP, et al. Am J Clin Oncol. 1982 Apr;5(2):221-5. doi: 10.1097/00000421-198204000-00071. Am J Clin Oncol. 1982. PMID: 7046414 Clinical Trial.

3

The treatment of extragonadal seminoma.

Jain KK, Bosl GJ, Bains MS, Whitmore WF, Golbey RB. Jain KK, et al. J Clin Oncol. 1984 Jul;2(7):820-7. doi: 10.1200/JCO.1984.2.7.820. J Clin Oncol. 1984. PMID: 6204019

4

VAB-6 as initial treatment of patients with advanced seminoma.

Stanton GF, Bosl GJ, Whitmore WF Jr, Herr H, Sogani P, Morse M, Golbey RB. Stanton GF, et al. J Clin Oncol. 1985 Mar;3(3):336-9. doi: 10.1200/JCO.1985.3.3.336. J Clin Oncol. 1985. PMID: 2579214

5

Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer.

Pfister DG, Bajorin D, Motzer R, Scher H, Louison C, Harrison L, Shah J, Strong E, Bosl G. Pfister DG, et al. Arch Otolaryngol Head Neck Surg. 1994 Jan;120(1):89-95. doi: 10.1001/archotol.1994.01880250077011. Arch Otolaryngol Head Neck Surg. 1994. PMID: 8274261 Clinical Trial.

6

Salvage laryngectomy for unsuccessful larynx preservation therapy.

Kraus DH, Pfister DG, Harrison LB, Spiro RH, Strong EW, Zelefsky M, Bosl GJ, Shah JP. Kraus DH, et al. Ann Otol Rhinol Laryngol. 1995 Dec;104(12):936-41. doi: 10.1177/000348949510401204. Ann Otol Rhinol Laryngol. 1995. PMID: 7492064

7

Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation.

Pfister DG, Harrison LB, Strong EW, Shah JP, Spiro RW, Kraus DH, Armstrong JG, Zelefsky MJ, Fass DE, Weiss MH, et al. Pfister DG, et al. J Clin Oncol. 1995 Mar;13(3):671-80. doi: 10.1200/JCO.1995.13.3.671. J Clin Oncol. 1995. PMID: 7884428 Clinical Trial.

8

Systemic chemotherapy in the management of bladder cancer.

Nanus DM, Bosl GJ. Nanus DM, et al. Cancer Treat Res. 1989;46:143-58. doi: 10.1007/978-1-4613-1595-7_8. Cancer Treat Res. 1989. PMID: 2577186 Review.

9

Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.

Motzer RJ, Sheinfeld J, Mazumdar M, Bajorin DF, Bosl GJ, Herr H, Lyn P, Vlamis V. Motzer RJ, et al. J Clin Oncol. 1995 Nov;13(11):2700-4. doi: 10.1200/JCO.1995.13.11.2700. J Clin Oncol. 1995. PMID: 7595727 Clinical Trial.

10

Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.

Bosl GJ, Geller NL, Cirrincione C, Nisselbaum J, Vugrin D, Whitmore WF Jr, Golbey RB. Bosl GJ, et al. Am J Med. 1983 Jul;75(1):29-35. doi: 10.1016/0002-9343(83)91164-6. Am J Med. 1983. PMID: 6190398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

72 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year